SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-025754
Filing Date
2021-05-10
Accepted
2021-05-10 07:05:23
Documents
2
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stok-8k_20210510.htm 8-K 30007
2 EX-99.1 stok-ex991_6.htm EX-99.1 222688
  Complete submission text file 0001564590-21-025754.txt   253881
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 21905197
SIC: 2834 Pharmaceutical Preparations